T1	Participants 37 96	posttransplant hypertension in kidney allograft recipients.
T2	Participants 216 234	kidney recipients.
T3	Participants 481 551	Thirty-two patients on antihypertensive treatment completed the study.
T4	Participants 1465 1492	kidney allograft recipients
